Invitreo Biosciences ApS: Financial statements 2022
CVR: 42514799
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Invitreo Biosciences ApS (CVR 42514799) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -17,659 and a net result of DKK -23,253. Equity in the 2022 report amounted to DKK -3,084.
- Gross Profit
- DKK -17,659
- Profit/Loss
- DKK -23,253
- Equity
- DKK -3,084
- Total Assets
- DKK 4,366
- Employees
- 0
Official annual report
Keep an eye on Invitreo Biosciences ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Invitreo Biosciences ApS has published its interim report for the period June 23, 2021 to December 31, 2021.
About Invitreo Biosciences ApS
Invitreo Biosciences ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company has been dissolved on 26 August 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -23,253 the year before. Equity in the 2023 report amounted to DKK -3,084.